Resources Contact Us Home
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination

Image Number 19 for United States Patent #5518725.

The invention relates to a vaccine which comprises an antigen and a lymphoid organ modifying agent. Suitable lymphoid organ modifying agents include 1,25-dihydroxy Vitamin D.sub.3, biologically active Vitamin D.sub.3 derivatives which are capable of activating the intracellular Vitamin D.sub.3 receptor, all trans-retinoic acid, retinoic acid derivatives, retinol, retinol derivatives and glucocorticoid. The vaccine composition may further comprise an immune response augmenting agent which enhances T cell lymphokine production. Suitable immune response augmenting agents include dehydroepiandrosterone (DHEA) and DHEA-derivatives. Examples of DHEA derivatives include DHEA-sulfate (DHEA-S), 16-.alpha.-bromo-DHEA, 7-oxo-DHEA, 16-.alpha.-Br-DHEA-S and 7-oxo-DHEA-S. The invention also relates to a method for inducing an antigen-specific mucosal immune response in a vertebrate animal which comprises administering a vaccine which comprises an antigen and a lymphoid organ modifying agent with or without an immune response augmenting agent to a site which drains into a peripheral lymphoid compartment.

  Recently Added Patents
Field emission cathode device and field emission display using the same
Vectorization of program code
Can seam inspection
Modular storage system
PVD coated tool
Method and receiver for jointly decoding received communication signals using maximum likelihood detection
  Randomly Featured Patents
Catalyst composition for preparation of polyethylene
Human engineered remote driving system
Alkoxyalkanoate esters of cyclaradine
Camptothecin analogs and methods of preparation thereof
Electromagnetic quadrupole circuit which independently corrects ac and dc components of correction current
Cellular phone
Low pressure pool cleaner system
Clamping element for connecting a motor shaft to a transmission via a hub